IGF1 and breast carcinoma: To determine the role the IGF-1 mTORC1 pathway and SRPK2 dynamics, breast cancer cells were serum starved overnight in the presence of either mTORC1 inhibitor, rapamycin, or vehicle and exposed to IGF-1 for various time points.